...
search icon
cprx-img

Catalyst Pharmaceuticals Inc Share Price

CPRX
NAQ
$24.33
+$0.73
(3.09%)
1D
Industry: Biotechnology Sector: Health Care

Catalyst Pharmaceuticals Inc Analyst Forecast

Catalyst Pharmaceuticals Inc Share Price Chart

Catalyst Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.90B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
13.9645
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.16M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.73
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$19.05 L
$26.58 H
$24.33

About Catalyst Pharmaceuticals Inc, Common Stock

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizures; Ruzurgi for the treatment of pediatric LEMS patients; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida. more

Industry: BiotechnologySector: Health Care

Catalyst Pharmaceuticals Inc Stock Returns

Time FrameCPRXSectorS&P500
1-Week Return-0.45%-1.08%-1.38%
1-Month Return8.86%-0.47%-1.81%
3-Month Return5.69%2.13%1.38%
6-Month Return20.51%17.04%5.68%
1-Year Return4.6%6.56%11.74%
3-Year Return56.56%16.78%65.15%
5-Year Return490.53%34.34%73.68%
10-Year Return1215.14%137.88%260.03%

Catalyst Pharmaceuticals Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue119.07M140.83M214.20M398.20M491.73M[{"date":"2020-12-31","value":24.21,"profit":true},{"date":"2021-12-31","value":28.64,"profit":true},{"date":"2022-12-31","value":43.56,"profit":true},{"date":"2023-12-31","value":80.98,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue17.04M21.88M34.39M51.97M68.84M[{"date":"2020-12-31","value":24.75,"profit":true},{"date":"2021-12-31","value":31.79,"profit":true},{"date":"2022-12-31","value":49.96,"profit":true},{"date":"2023-12-31","value":75.48,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit102.03M118.95M179.81M346.24M422.89M[{"date":"2020-12-31","value":24.13,"profit":true},{"date":"2021-12-31","value":28.13,"profit":true},{"date":"2022-12-31","value":42.52,"profit":true},{"date":"2023-12-31","value":81.87,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin85.69%84.46%83.94%86.95%86.00%[{"date":"2020-12-31","value":98.55,"profit":true},{"date":"2021-12-31","value":97.14,"profit":true},{"date":"2022-12-31","value":96.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.91,"profit":true}]
Operating Expenses60.73M66.56M77.97M259.43M227.76M[{"date":"2020-12-31","value":23.41,"profit":true},{"date":"2021-12-31","value":25.66,"profit":true},{"date":"2022-12-31","value":30.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":87.8,"profit":true}]
Operating Income41.30M52.38M101.84M86.81M195.12M[{"date":"2020-12-31","value":21.17,"profit":true},{"date":"2021-12-31","value":26.85,"profit":true},{"date":"2022-12-31","value":52.19,"profit":true},{"date":"2023-12-31","value":44.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense---12.37M37.20M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":33.26,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income41.89M52.67M104.72M94.51M216.26M[{"date":"2020-12-31","value":19.37,"profit":true},{"date":"2021-12-31","value":24.35,"profit":true},{"date":"2022-12-31","value":48.42,"profit":true},{"date":"2023-12-31","value":43.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income Taxes(33.09M)13.19M21.64M23.10M52.37M[{"date":"2020-12-31","value":-63.19,"profit":false},{"date":"2021-12-31","value":25.17,"profit":true},{"date":"2022-12-31","value":41.32,"profit":true},{"date":"2023-12-31","value":44.11,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes---71.41M163.89M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":43.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Continuous Operations74.98M39.48M83.08M62.04M163.89M[{"date":"2020-12-31","value":45.75,"profit":true},{"date":"2021-12-31","value":24.09,"profit":true},{"date":"2022-12-31","value":50.69,"profit":true},{"date":"2023-12-31","value":37.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income74.98M39.48M83.08M71.41M163.89M[{"date":"2020-12-31","value":45.75,"profit":true},{"date":"2021-12-31","value":24.09,"profit":true},{"date":"2022-12-31","value":50.69,"profit":true},{"date":"2023-12-31","value":43.57,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
EPS (Diluted)0.410.370.740.811.31[{"date":"2020-12-31","value":31.3,"profit":true},{"date":"2021-12-31","value":28.24,"profit":true},{"date":"2022-12-31","value":56.49,"profit":true},{"date":"2023-12-31","value":61.83,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Catalyst Pharmaceuticals Inc Ratios

Catalyst Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

CPRX
Cash Ratio 5.36
Current Ratio 6.62
Quick Ratio 6.40

Catalyst Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CPRX
ROA (LTM) 17.74%
ROE (LTM) 27.52%

Catalyst Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CPRX
Debt Ratio Lower is generally better. Negative is bad. 0.12
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.88

Catalyst Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CPRX
Trailing PE 13.96
Forward PE 10.63
P/S (TTM) 5.02
P/B 3.15
Price/FCF 89
EV/R 3.83
EV/Ebitda 7.46
PEG NM

FAQs

What is Catalyst Pharmaceuticals Inc share price today?

Catalyst Pharmaceuticals Inc (CPRX) share price today is $24.33

Can Indians buy Catalyst Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Catalyst Pharmaceuticals Inc (CPRX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CPRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Catalyst Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Catalyst Pharmaceuticals Inc (CPRX) via the Vested app. You can start investing in Catalyst Pharmaceuticals Inc (CPRX) with a minimum investment of $1.

How to invest in Catalyst Pharmaceuticals Inc shares from India?

You can invest in shares of Catalyst Pharmaceuticals Inc (CPRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in CPRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Catalyst Pharmaceuticals Inc shares
What is Catalyst Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Catalyst Pharmaceuticals Inc (CPRX) is $26.58. The 52-week low price of Catalyst Pharmaceuticals Inc (CPRX) is $19.05.

What is Catalyst Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Catalyst Pharmaceuticals Inc (CPRX) is 13.9645

What is Catalyst Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Catalyst Pharmaceuticals Inc (CPRX) is 3.15

What is Catalyst Pharmaceuticals Inc dividend yield?

The dividend yield of Catalyst Pharmaceuticals Inc (CPRX) is 0.00%

What is the Market Cap of Catalyst Pharmaceuticals Inc?

The market capitalization of Catalyst Pharmaceuticals Inc (CPRX) is $2.90B

What is Catalyst Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Catalyst Pharmaceuticals Inc is CPRX

How Can Investors Use Catalyst Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Catalyst Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Catalyst Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Catalyst Pharmaceuticals Inc shares for Indian investors?

When investing in Catalyst Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Catalyst Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Catalyst Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Catalyst Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Catalyst Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top